Pharma sector earnings rise 5pc despite weak sales growth in 3QCY26
KARACHI: Pakistan’s listed pharmaceutical companies recorded a 5 percent year-on-year increase in cumulative earnings during the third quarter of calendar year 2026, despite a 1 percent decline in revenue, as improved gross margins and cost optimisation supported profitability amid export disruptions and higher trade discounts. A sample of nine listed pharmaceutical companies, representing…

Read at Business Recorder(opens in a new tab)
Full coverage
Pharma sector earnings rise 5pc despite weak sales growth in 3QCY26 (opens Business Recorder in a new tab)
KARACHI: Pakistan’s listed pharmaceutical companies recorded a 5 percent year-on-year increase in cumulative earnings during the third quarter of calendar year 2026, despite a 1 percent decline in revenue, as improved gross margins and cost optimisation…

